EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microbiome-Derived Effectors and Convergent Host Pathways in Organ Injury and Fibrosis

Valeria Fridman D'Alessandro, Hajime Fujimoto, Corina N D'Alessandro-Gabazza, Masaaki Toda, Romil Shah, Kota Nishihama, Osamu Hataji, Esteban C Gabazza, Deborah Leckband, Isaac Cann, Tetsu Kobayashi, Taro Yasuma

Frontiers in Bioscience-Landmark · 16.06.2026 · 31 (6)

DOI: 10.31083/fbl51062 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 16.06.2026. Verfasst von Valeria Fridman D'Alessandro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Mie University Faculty and Graduate School of Medicine, 514-8507 Tsu, Mie, Japan. Hauptthemen laut MEDLINE: Microbiota, Dysbiosis, Gastrointestinal Microbiome. Die Arbeit nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Science and Technology Agency (JST), Japan Society for the Promotion of Science, 2022 Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human microbiome functions as an endocrine-like biochemical network that generates metabolites, structural ligands, and peptides capable of shaping host physiology. Under physiological conditions, these microbiome-derived effectors contribute to epithelial integrity, immune homeostasis, metabolic regulation, and tissue resilience. During dysbiosis, however, the composition and systemic distribution of these effectors are altered, shifting host responses toward injury. Despite their chemical diversity, microbiome-derived signals converge on a limited set of host pathways, including pattern-recognition receptor activation, mitochondrial dysfunction, apoptosis and senescence, inflammatory amplification, and fibrosis, which collectively determine tissue vulnerability across organ systems. This framework links gut imbalance to disorders such as pulmonary fibrosis, acute lung injury, chronic kidney disease, and hepatobiliary inflammation. Microbial peptides represent an emerging layer of regulation. Among these peptides, corisin exemplifies how discrete microbial effectors can directly engage intracellular targets and amplify tissue injury. Together, these observations reframe microbiome-associated disease as a disorder of microbial chemistry and host pathway activation, thereby providing a foundation for mechanism-based biomarkers and targeted therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrobiotaDysbiosisGastrointestinal MicrobiomeHumansAnimalsFibrosis

Stichwörter der Autor:innen

bile acidscoagulopathycorisindysbiosisfibrosishost-microbe interactionsinflammationmicrobial metabolitesmicrobiomepeptidesshort-chain fatty acidstryptophan metabolism

Autor:innen und Institutionen

  • Department of Immunology, Mie University Faculty and Graduate School of Medicine, 514-8507 Tsu, Mie, Japan.
  • Department of Pulmonary and Critical Care Medicine, Diabetes, Metabolism and Endocrinology, Mie University Faculty and Graduate School of Medicine, 514-8507 Tsu, Mie, Japan.
  • Microbiome Research Center, Mie University, 514-8507 Tsu, Mie, Japan.
  • Department of Chemical and Biomolecular Engineering, University of Illinois Urbana-Champaign, Urbana, IL 61801-2302, USA.
  • Respiratory Center, Saiseikai Matsusaka Municipal Hospital, 515-8544 Matsusaka, Mie, Japan.
  • Department of Animal Sciences, University of Illinois Urbana-Champaign, Urbana, IL 61801-3838, USA.

Förderung

  • Japan Science and Technology Agency (JST)
  • Japan Society for the Promotion of Science
  • 2022 Takeda Science Foundation
  • 2023 Takeda Science Foundation
  • 2025-2026 MSD Life Science Foundation
  • 2025-2026 TERUMO Life Science Foundation
  • Daiwa Security Foundation 2024

Zitieren

APA

D'Alessandro, V. F., Fujimoto, H., D'Alessandro-Gabazza, C. N., Toda, M., Shah, R., Nishihama, K., Hataji, O., Gabazza, E. C., Leckband, D., Cann, I., Kobayashi, T., & Yasuma, T. (2026). Microbiome-Derived Effectors and Convergent Host Pathways in Organ Injury and Fibrosis. Frontiers in Bioscience-Landmark, 31(6). https://doi.org/10.31083/fbl51062

Vancouver

D'Alessandro VF, Fujimoto H, D'Alessandro-Gabazza CN, Toda M, Shah R, Nishihama K, et al. Microbiome-Derived Effectors and Convergent Host Pathways in Organ Injury and Fibrosis. Frontiers in Bioscience-Landmark. 2026;31(6). doi:10.31083/fbl51062

BibTeX
@article{DAlessandro2026,
  author = {D'Alessandro, Valeria Fridman and Fujimoto, Hajime and D'Alessandro-Gabazza, Corina N and Toda, Masaaki and Shah, Romil and Nishihama, Kota and Hataji, Osamu and Gabazza, Esteban C and Leckband, Deborah and Cann, Isaac and Kobayashi, Tetsu and Yasuma, Taro},
  title = {Microbiome-Derived Effectors and Convergent Host Pathways in Organ Injury and Fibrosis},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  volume = {31},
  number = {6},
  doi = {10.31083/fbl51062}
}
Kostenlos starten →